Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
16.02.24
€38.99
16.02.25
26.61%
20.05.24

Royal Bank of Canada 
16.02.24 50%
buy
Alkermes plc

Start price
Target price
Perf. (%)
€29.80
16.02.24
€36.20
16.02.25
-24.83%
20.05.24

Piper Sandler 
16.02.24 50%
buy
Ironwood Pharmaceuticals

Start price
Target price
Perf. (%)
€13.50
16.02.24
€19.49
16.02.25
-56.30%
20.05.24

Piper Sandler 
16.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
16.02.24
€47.44
16.02.25
-
29.01.24

Morgan Stanley 
16.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
16.02.24
€47.44
16.02.25
-
29.01.24

Morgan Stanley 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€139.00
16.02.24
€209.30
16.02.25
-1.01%
20.05.24

Chardan Capital 
16.02.24 50%
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€191.20
15.02.24
€204.23
15.02.25
-17.34%
17.05.24

KeyCorp 
15.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.00
15.02.24
€185.66
15.02.25
0.44%
20.05.24

Needham & Company LLC 
15.02.24 50%
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€74.00
15.02.24
€87.34
15.02.25
-4.64%
20.05.24

UBS Group AG 
15.02.24 50%
buy
Ultragenyx Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€44.60
15.02.24
€105.84
15.02.25
-13.90%
20.05.24

Cantor Fitzgerald 
15.02.24 50%
sell
Mirati Therapeutics Inc.

Start price
Target price
Perf. (%)
€53.84
15.02.24
-
15.02.25
-
23.01.24

StockNews.com 
15.02.24 50%
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€369.50
15.02.24
€419.64
15.02.25
-0.51%
20.05.24

UBS Group AG 
15.02.24 50%
sell
Evotec SE

Start price
Target price
Perf. (%)
€13.43
15.02.24
-
15.02.25
-27.89%
20.05.24

DirectorDealer 
15.02.24 50%
buy
Davita Inc.

Start price
Target price
Perf. (%)
€115.05
14.02.24
€124.89
14.02.25
12.30%
20.05.24

UBS Group AG 
14.02.24 50%
buy
Medpace Holdings Inc

Start price
Target price
Perf. (%)
€364.00
14.02.24
€380.17
14.02.25
0.99%
20.05.24

Robert W. Baird 
14.02.24 50%
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€74.00
14.02.24
€88.53
14.02.25
-4.64%
20.05.24

Citigroup Inc. 
14.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€152.00
14.02.24
€219.11
14.02.25
-9.47%
20.05.24

Royal Bank of Canada 
14.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€199.10
14.02.24
-
14.02.25
26.47%
20.05.24

StockNews.com 
14.02.24 50%
buy
Bruker Corp.

Start price
Target price
Perf. (%)
€73.50
14.02.24
€84.02
14.02.25
-3.99%
20.05.24

JPMorgan Chase & Co. 
14.02.24 50%
buy
Omnicell Inc.

Start price
Target price
Perf. (%)
€25.60
09.02.24
€35.23
09.02.25
9.38%
20.05.24

Benchmark Co. 
09.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
08.02.24
€48.24
08.02.25
-
29.01.24

JPMorgan Chase & Co. 
08.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
08.02.24
€48.24
08.02.25
-
29.01.24

JPMorgan Chase & Co. 
08.02.24 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€28.61
08.02.24
€83.48
08.02.25
-19.54%
16.05.24

HC Wainwright 
08.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
08.02.24
€55.66
08.02.25
-
29.01.24

Citigroup Inc. 
08.02.24 50%
buy
QIAGEN NV

Start price
Target price
Perf. (%)
€40.47
08.02.24
€55.66
08.02.25
-
29.01.24

Citigroup Inc. 
08.02.24 50%